Might rapid virological response be used as a stopping rule in liver transplant recipients treated with pegylated interferon plus ribavirin?

Liver Transpl. 2008 Sep;14(9):1383-4; author reply 1385. doi: 10.1002/lt.21570.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Cohort Studies
  • Cyclosporine / pharmacology
  • Hepacivirus / metabolism
  • Hepatitis C / virology
  • Humans
  • Immunosuppressive Agents / pharmacology
  • Interferons / administration & dosage*
  • Kinetics
  • Liver / pathology
  • Liver / virology
  • Liver Transplantation / methods*
  • Odds Ratio
  • Polyethylene Glycols / metabolism*
  • Ribavirin / administration & dosage*
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Immunosuppressive Agents
  • Polyethylene Glycols
  • Ribavirin
  • Cyclosporine
  • Interferons